Stephen P Richman

Professor

  • 1723 Citations
1967 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Stephen P Richman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Mycobacterium bovis Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Cell Wall Skeleton Medicine & Life Sciences
BCG Vaccine Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1967 2019

2 Citations (Scopus)
Hepatocellular Carcinoma
Biomarkers
Programmed Cell Death 1 Receptor
Staining and Labeling
pembrolizumab
28 Citations (Scopus)

Levels of symptom burden during chemotherapy for advanced lung cancer: Differences between public hospitals and a tertiary cancer center

Cleeland, C. S., Mendoza, T. R., Wang, X. S., Woodruff, J. F., Palos, G. R., Richman, S. P., Nazario, A., Lynch, G. R., Liao, K. P., Mobley, G. M. & Lu, C., Jul 20 2011, In : Journal of Clinical Oncology. 29, 21, p. 2859-2865 7 p.

Research output: Contribution to journalArticle

Public Hospitals
Lung Neoplasms
Drug Therapy
Neoplasms
Vulnerable Populations
53 Citations (Scopus)

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

Lobo, C., Lopes, G., Baez, O., Castrellon, A., Ferrell, A., Higgins, C., Hurley, E., Hurley, J., Reis, I., Richman, S. P., Seo, P. H., Silva, O., Slingerland, J. M., Tukia, K., Welsh, C. & Glück, S., Sep 1 2010, In : Breast Cancer Research and Treatment. 123, 2, p. 427-435 9 p.

Research output: Contribution to journalArticle

gemcitabine
Breast Neoplasms
Disease-Free Survival
Nanoparticles
Therapeutics
71 Citations (Scopus)

Pain education for underserved minority cancer patients: A randomized controlled trial

Anderson, K. O., Mendoza, T. R., Payne, R., Valero, V., Palos, G. R., Nazario, A., Richman, S. P., Hurley, J., Gning, I., Lynch, G. R., Kalish, D. & Cleeland, C. S., Dec 15 2004, In : Journal of Clinical Oncology. 22, 24, p. 4918-4925 8 p.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Education
Pain
Neoplasms
Patient Education
170 Citations (Scopus)

Cancer pain management among underserved minority outpatients: Perceived needs and barriers to optimal control

Anderson, K. O., Richman, S. P., Hurley, J., Palos, G., Valero, V., Mendoza, T. R., Gning, I. & Cleeland, C. S., Apr 15 2002, In : Cancer. 94, 8, p. 2295-2304 10 p.

Research output: Contribution to journalArticle

Pain Management
Outpatients
Hispanic Americans
African Americans
Pain